1. Home
  2. XEL vs EW Comparison

XEL vs EW Comparison

Compare XEL & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Energy Inc.

XEL

Xcel Energy Inc.

N/A

Current Price

$81.97

Market Cap

49.2B

Sector

Utilities

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$85.44

Market Cap

50.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XEL
EW
Founded
1909
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.2B
50.2B
IPO Year
2003
1999

Fundamental Metrics

Financial Performance
Metric
XEL
EW
Price
$81.97
$85.44
Analyst Decision
Buy
Buy
Analyst Count
14
21
Target Price
$84.36
$96.47
AVG Volume (30 Days)
4.4M
4.8M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
2.76%
N/A
EPS Growth
N/A
N/A
EPS
3.42
1.83
Revenue
$11,537,000,000.00
$6,067,600,000.00
Revenue This Year
$9.67
$13.39
Revenue Next Year
$8.02
$9.78
P/E Ratio
$24.13
$44.69
Revenue Growth
N/A
11.55
52 Week Low
$65.21
$65.94
52 Week High
$84.23
$87.89

Technical Indicators

Market Signals
Indicator
XEL
EW
Relative Strength Index (RSI) 59.65 57.77
Support Level $71.95 $81.04
Resistance Level $82.51 $87.22
Average True Range (ATR) 1.36 2.11
MACD -0.25 0.32
Stochastic Oscillator 56.49 80.65

Price Performance

Historical Comparison
XEL
EW

About XEL Xcel Energy Inc.

Xcel Energy manages utilities serving 3.9 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: